Skip to main content
Log in

Depression, SLE and diabetes drug markets set for growth

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Decision Resources.Patent Protection of Key Blockbuster Agents for Major Depression Will Drive $500 Million Market Growth in Europe and Japan Through 2018. Media Release: 17 Aug 2009. Available from: URL: http://www.decisionresources.com

  2. Decision Resources.Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly $2 Billion in 2018. Media Release: 11 Aug 2009. Available from: URL: http://www.decisionresources.com

  3. Frost & Sullivan.Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan. Media Release: 19 Aug 2009. Available from: URL: http://www.frost.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Depression, SLE and diabetes drug markets set for growth. Pharmacoecon. Outcomes News 586, 10 (2009). https://doi.org/10.2165/00151234-200905860-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905860-00026

Keywords

Navigation